Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.98 is 91% above its 5-year average of -10.90, near the high end of its 5-year range (-27.27–-0.98).
As of the fiscal period ended Tuesday, June 30, 2026. 3.45% above its 12-month average of -1.02.
Reported quarterly EPS; no daily interpolation. Q4 FY2026 (2026-06-30): -0.27.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 29 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:05:53.288Z. Historical observations retain their original dates. Historical series through 2019-09-30.
EARNINGS PER SHARE (EPS)
-0.98
EARNINGS PER SHARE (EPS) AVG TTM
-1.02
EARNINGS PER SHARE (EPS) AVG 3Y
-4.71
EARNINGS PER SHARE (EPS) AVG 5Y
-10.90
EARNINGS PER SHARE (EPS) AVG 10Y
-44.28
EARNINGS PER SHARE (EPS) AVG 15Y
-54.51
EARNINGS PER SHARE (EPS) AVG 20Y
-86.74
CURRENT VS TTM AVG
+3.45%
CURRENT VS 3Y AVG
+79.18%
CURRENT VS 5Y AVG
+91.01%
CURRENT VS 10Y AVG
+97.79%
CURRENT VS 15Y AVG
+98.20%
CURRENT VS 20Y AVG
+98.87%
Benitec Biopharma Inc.
Market Cap
$304.88M
Earnings Per Share (EPS)
-0.98
TTM Avg
-1.02
3Y Avg
-4.71
5Y Avg
-10.90
Market Cap
$309.45M
Earnings Per Share (EPS)
-0.23
TTM Avg
-0.20
3Y Avg
-1.19
5Y Avg
-1.02
Market Cap
$316.53M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.02
3Y Avg
-0.02
5Y Avg
-0.02
Market Cap
$290.87M
Earnings Per Share (EPS)
-1.99
TTM Avg
-1.79
3Y Avg
-1.44
5Y Avg
-2.04
Market Cap
$287.58M
Earnings Per Share (EPS)
N/A
TTM Avg
-2880.36
3Y Avg
-1920.24
5Y Avg
-1440.18
Market Cap
$323.01M
Earnings Per Share (EPS)
-0.63
TTM Avg
-0.48
3Y Avg
-0.42
5Y Avg
-0.42
Market Cap
$286.40M
Earnings Per Share (EPS)
-1.11
TTM Avg
-0.10
3Y Avg
-2.07
5Y Avg
-8.75
Market Cap
$328.40M
Earnings Per Share (EPS)
-1.00
TTM Avg
-1.40
3Y Avg
-2.02
5Y Avg
-1.91
Market Cap
$281.16M
Earnings Per Share (EPS)
-1.21
TTM Avg
-0.67
3Y Avg
-1.32
5Y Avg
-1.70
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | $304.88M | -0.98 | -1.02 | -4.71 | -10.90 |
| Standard BioTools Inc. (LAB)vs › | $309.45M | -0.23 | -0.20 | -1.19 | -1.02 |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $316.53M | N/A | -0.02 | -0.02 | -0.02 |
| Larimar Therapeutics, Inc. (LRMR)vs › | $290.87M | -1.99 | -1.79 | -1.44 | -2.04 |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $287.58M | N/A | -2880.36 | -1920.24 | -1440.18 |
| CapsoVision, Inc. (CV)vs › | $323.01M | -0.63 | -0.48 | -0.42 | -0.42 |
| Abeona Therapeutics Inc. (ABEO)vs › | $286.40M | -1.11 | -0.10 | -2.07 | -8.75 |
| C4 Therapeutics, Inc. (CCCC)vs › | $328.40M | -1.00 | -1.40 | -2.02 | -1.91 |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.16M | -1.21 | -0.67 | -1.32 | -1.70 |
| Cabaletta Bio, Inc. (CABA)vs › | $329.37M | -1.58 | -1.99 | -1.86 | -1.78 |
Trailing EPS (TTM)
$-0.98
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-06-30 | -0.98 |
| 2025-06-30 | -1.05 |
| 2024-06-30 | -2.68 |
| 2023-06-30 | -14.12 |
| 2022-06-30 | -19.31 |
| 2021-06-30 | -27.27 |
| 2020-06-30 | -69.09 |
| 2019-06-30 | 19.98 |
| 2018-06-30 | -76.69 |
| 2017-06-30 | -48.82 |
| 2016-06-30 | -247.03 |
| 2015-06-30 | -150.12 |
| 2014-06-30 | -71.92 |
| 2013-06-30 | -76.03 |
| 2012-06-30 | -111.83 |
| 2011-06-30 | -167.70 |
| 2010-06-30 | -214.89 |
| 2009-06-30 | -120.37 |
| 2008-06-30 | -173.85 |
| 2007-06-30 | -205.01 |
| 2006-06-30 | -42.70 |
| 2005-06-30 | -2047.27 |
| 2004-06-30 | -1349.77 |
